NEW ZEALAND MEDICAL JOURNAL最新文献_第2页

Insights into a large waterborne Campylobacter outbreak from a cross-sectional telephone survey. 横断面电话调查对大型水传播弯曲杆菌爆发的见解。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-05-08 DOI: 10.26635/6965.7169

Brent J Gilpin, Shevaun Paine, Tim Wood, Carla J Eaton, Claire Newbern, Tiffany A Walker, Graham Mackereth, Nicholas Jones

{"title":"Insights into a large waterborne Campylobacter outbreak from a cross-sectional telephone survey.","authors":"Brent J Gilpin, Shevaun Paine, Tim Wood, Carla J Eaton, Claire Newbern, Tiffany A Walker, Graham Mackereth, Nicholas Jones","doi":"10.26635/6965.7169","DOIUrl":"https://doi.org/10.26635/6965.7169","url":null,"abstract":"Aim: To understand the impacts and responses of households during the Havelock North drinking water outbreak.Methods: Fifty days after the outbreak, cross-sectional telephone questionnaires were administered to a cohort of households.Results: Seventy-six percent of the people surveyed indicated drinking unboiled tap water, with 35% of those developing diarrhoea, compared with only 3% of those who did not drink the water. Symptoms correlated with increasing quantities of water consumed, and 31% reported a relapse of diarrhoea after initial improvement. The attack rate among those less than 20 years old (41%), was higher than those aged 50 and over (22%). Individuals with diarrhoea had an average of 7 days off school or work. Only 27% of individuals with diarrhoea visited a doctor or hospital, but 72% were in households that purchased items from a pharmacy. Following the issue of a boil water notice, 82% of households boiled their water, and 67% purchased bottled water, with only 5% taking no precautions. A third of the 169 households surveyed continued one or both of these responses for at least 3 weeks after the boil water notice was lifted.Conclusions: Telephone surveys provided insights into the outbreak not otherwise obtainable from routine surveillance systems, including the attack rates among different demographics, size of the outbreak (5,540 cases within Havelock North), potential of pharmacy-based surveillance, compliance with public health messaging and the need to communicate to households when the water is safe to drink.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1634","pages":"12-23"},"PeriodicalIF":1.3,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147844676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The impact of cultural concordance between health professionals and patients: a narrative review. 卫生专业人员和患者之间文化一致性的影响：叙述回顾。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-05-08 DOI: 10.26635/6965.7278

Belinda Loring, Papaarangi Reid

{"title":"The impact of cultural concordance between health professionals and patients: a narrative review.","authors":"Belinda Loring, Papaarangi Reid","doi":"10.26635/6965.7278","DOIUrl":"https://doi.org/10.26635/6965.7278","url":null,"abstract":"Aim: The aim of this article is to summarise international evidence on the impacts of cultural/ethnic concordance between patients and health professionals and to discuss the implications for New Zealand.Method: Database searches were conducted from August to September 2025 using Scopus, Embase and PubMed, using key terms related to health outcomes and cultural/ethnic concordance.Results: A total of 25 relevant systematic reviews, meta-analyses and research studies were included for analysis. Overall, evidence is predominately from the United States of America and findings are variable. Cultural concordance is associated with improved communication quality, trust, satisfaction and perceived respect. Concordance is also associated with improved healthcare utilisation, medication adherence and uptake of preventative interventions. Some studies found concordance was associated with differences in clinical decision-making. Impact on clinical outcomes is mixed, with some studies finding concordance has a positive impact on caesarean section rates, diabetes management, surgical outcomes and addiction treatment, while others found no impact.Conclusion: Cultural concordance between patients and their health professionals matters, with evidence of impact on patient experience, communication quality, engagement and adherence, clinical decision-making and some clinical outcomes. Findings are inconsistent: the strength of association and groups which see the greatest benefit vary between studies. To reduce health inequities, we need to increase the diversity of the workforce and train all health professionals to provide non-racist, equitable care.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1634","pages":"65-78"},"PeriodicalIF":1.3,"publicationDate":"2026-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147844709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reluctant victims: healthcare workers and workplace violence. 不情愿的受害者：卫生保健工作者和工作场所暴力。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-05-08 DOI: 10.26635/6965.7345

Wendy Strawbridge, Ruth Money, Lillian Ng

引用次数: 0

Lung cancer in Aotearoa New Zealand: paradoxes of progress, precision and prevention. 新西兰奥特罗阿的肺癌：进步、精准和预防的悖论。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-04-17 DOI: 10.26635/6965.e1633

Lutz Beckert, Frank Frizelle

引用次数: 0

The use of blood biomarkers in lung cancer screening in Aotearoa New Zealand: a cross-sectional survey of Māori perspectives and preferences. 血液生物标志物在新西兰奥特罗阿肺癌筛查中的使用：Māori观点和偏好的横断面调查。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-04-17 DOI: 10.26635/6965.7273

Sarah Colhoun, Tayla Schaapveld, Karen Bartholomew, Kate Parker, Rob McNeill, Erena Wikaire, Sharon McCook, Aroha Haggie, Billie Baty, Anna Maxwell, Erin Chambers, Jenny Richards, Sue Crengle

{"title":"The use of blood biomarkers in lung cancer screening in Aotearoa New Zealand: a cross-sectional survey of Māori perspectives and preferences.","authors":"Sarah Colhoun, Tayla Schaapveld, Karen Bartholomew, Kate Parker, Rob McNeill, Erena Wikaire, Sharon McCook, Aroha Haggie, Billie Baty, Anna Maxwell, Erin Chambers, Jenny Richards, Sue Crengle","doi":"10.26635/6965.7273","DOIUrl":"https://doi.org/10.26635/6965.7273","url":null,"abstract":"Aim: As part of a broader lung cancer screening (LCS) research programme, this study explored Māori views on providing blood samples for LCS to inform future development in Aotearoa New Zealand.Methods: Two groups (potential \"screenees\", and their whānau tautoko [support people]) from Te Tai Tokerau (Northland) and Tāmaki Makaurau (Auckland) completed surveys about LCS design, including comfort with blood donation and key factors in blood collection and use. Descriptive statistics and Fisher's tests were used to analyse responses and demographic differences.Results: Most participants (83.7% screenees; 81.4% whānau) were at least \"comfortable\" donating blood. Key priorities were clear information about blood use (35.0%; 35.8%), protecting the health of future generations (24.1%; 23.8%) and being able to consent to specific uses (23.6%; 27.6%). Participants from Te Tai Tokerau were less comfortable donating blood than those in Tāmaki Makaurau, with additional demographic differences noted.Conclusions: Māori participants generally supported using blood samples in LCS but with regional differences. Future LCS initiatives should uphold Māori principles, including community partnership, return of benefit to whānau, management of potential harms and protection of Indigenous data and tissue sovereignty through transparent, culturally safe and trusted engagement processes.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1633","pages":"76-92"},"PeriodicalIF":1.3,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147700420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dietary sugar intake as a risk factor for early-onset colorectal cancer in young New Zealanders. 膳食糖摄入量是新西兰年轻人早发性结直肠癌的危险因素。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-04-17 DOI: 10.26635/6965.7378

Krista L Dawson, Oliver Waddell, Frank Frizelle, Jacqueline I Keenan

引用次数: 0

Neoadjuvant systemic therapy in stage III and IV resectable melanoma: an update to management and future directions. III期和IV期可切除黑色素瘤的新辅助全身治疗：管理和未来方向的更新。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-04-17 DOI: 10.26635/6965.7104

Samuel Reddish, Sarah Seol, Gareth Rivalland, Richard Cw Martin, Michael Russell

{"title":"Neoadjuvant systemic therapy in stage III and IV resectable melanoma: an update to management and future directions.","authors":"Samuel Reddish, Sarah Seol, Gareth Rivalland, Richard Cw Martin, Michael Russell","doi":"10.26635/6965.7104","DOIUrl":"https://doi.org/10.26635/6965.7104","url":null,"abstract":"Aim: This article aims to review the role of neoadjuvant systemic therapy (NAST) in the management of clinical stage III or IV resectable melanoma. The review focusses on the evidence behind neoadjuvant systemic therapies and on developing a protocol for widespread implementation within the New Zealand health system. We outline suggested future directions for this evolving treatment.Methods: A detailed literature review was conducted, examining the rationale, mechanisms of action and recent clinical trial data supporting the use of NAST in melanoma management.Results: NAST provides notable immunological advantages by harnessing tumour antigen presence in situ, enhancing immune response and improving event-free survival (EFS) rates. Recent randomised phase II and III controlled trials have demonstrated significant improvements in EFS rates with NAST compared to standard adjuvant therapy alone. The SWOG-S1801 trial reported a 2-year EFS rate of 72% with neoadjuvant-adjuvant pembrolizumab compared to 49% for adjuvant-only therapy. The NADINA trial found a remarkable increase in 1-year EFS with neoadjuvant ipilimumab and nivolumab (83.7%) compared to adjuvant nivolumab alone (57.2%).Conclusion: Current evidence strongly supports incorporating NAST into standard clinical practice for resectable clinical stage III and IV melanoma, promising substantial improvements in patient outcomes with acceptable safety profiles.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1633","pages":"93-99"},"PeriodicalIF":1.3,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147700436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Physiotherapist-led triage within orthopaedic spine consultation: evaluation of a novel secondary care model of care. 骨科脊柱会诊中物理治疗师主导的分诊：一种新型二级护理模式的评估。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-04-17 DOI: 10.26635/6965.7289

Rohil V Chauhan, Aanirudh Kheterpal, Anand H Segar

{"title":"Physiotherapist-led triage within orthopaedic spine consultation: evaluation of a novel secondary care model of care.","authors":"Rohil V Chauhan, Aanirudh Kheterpal, Anand H Segar","doi":"10.26635/6965.7289","DOIUrl":"https://doi.org/10.26635/6965.7289","url":null,"abstract":"Aim: Timely access for orthopaedic spine consultation remains a challenge due to increasing demand and workforce constraints. Integrating advanced physiotherapy consultation models within orthopaedic services is an emerging strategy to streamline care. While common in New Zealand's tertiary care sector, comparable models in secondary care are lacking. This study evaluated the outcomes of a novel physiotherapist-integrated orthopaedic consultation model in secondary care.Methods: A retrospective review of patients seen from March to July 2023 was conducted using a five-step physiotherapist-integrated orthopaedic consultation model to assess management decisions, patient satisfaction, impact on consultation wait times and service capacity, and diagnostic concordance.Results: Among 233 patients (mean age 46.8 years; 53.6% male), 73.4% presented with lower back and associated lower limb symptoms. Most (74.7%) were managed non-operatively, 25.3% underwent surgical workup and 10.7% proceeded to surgery. Patient satisfaction was high (overall mean 91.3%), with highest scores for quality of care (92.3%) and explanation of treatment/expected outcomes (91.7%). While mean consultation wait times were longer than the 2021 pre-model cohort (63 vs 47.4 days), service capacity increased by 32%. Across three magnetic resonance imaging variables, diagnostic concordance was substantial (overall agreement: 78.1%; mean kappa: 0.65 [0.63-0.68]).Conclusion: A physiotherapist-integrated orthopaedic consultation model in secondary care is highly accepted by patients, increases service capacity and broadens multidisciplinary decision-making capacity. While a model as such is theoretically positioned to reduce consultation wait times, this was not observed in the present analysis-reflecting a growing unmet need for orthopaedic consultation in secondary care.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1633","pages":"65-75"},"PeriodicalIF":1.3,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147700432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The architecture of exception: a multidimensional analysis of the 2025 puberty blocker ban. 例外的架构：2025年青春期阻滞剂禁令的多维分析。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-04-17 DOI: 10.26635/6965.7314

Dylan A Mordaunt

{"title":"The architecture of exception: a multidimensional analysis of the 2025 puberty blocker ban.","authors":"Dylan A Mordaunt","doi":"10.26635/6965.7314","DOIUrl":"https://doi.org/10.26635/6965.7314","url":null,"abstract":"Aim: Our aim was to analyse how New Zealand's 2025 restriction on initiating puberty blockers for people aged <18 was translated into delegated medicines regulation and whether the public record reflects a differential evidentiary and governance standard.Methods: We assembled a 67-document policy corpus and extracted a 32-field matrix from 12 core documents (statutory instruments, the Ministry of Health - Manatū Hauora evidence brief and key institutional/stakeholder texts). Using a seven-pillar \"Regulatory Exceptionalism\" framework, we analysed evidentiary framing, process signals and rights/equity treatment.Results: The restriction was made by regulation under section 105 of the Medicines Act 1981 (signed on 17 November 2025; announced on 19 November 2025; gazetted on 20 November 2025; scheduled to commence on 19 December 2025). The record treats evidentiary uncertainty as a categorical trigger for restricting initiation, bypassing routine governance tools used to manage off‑label prescribing (professional standards, service governance, monitoring and auditing). Executive texts provide limited explicit engagement with proportionality, discrimination and equity obligations, and leave review criteria and decision thresholds under-specified.Conclusion: The decision is consistent with Regulatory Exceptionalism: higher evidentiary and governance standards are applied to a discrete population/indication than elsewhere in paediatrics. If uncertainty is the operative concern, proportionate alternatives include published multidisciplinary team thresholds, registry-based monitoring and time-limited policy with explicit review triggers rather than categorical prohibition.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"139 1633","pages":"38-54"},"PeriodicalIF":1.3,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147700388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Masquerading as adhesions: left paraduodenal hernia, a congenital cause of small bowel obstruction. 伪装成粘连：左侧十二指肠旁疝，先天性小肠梗阻的原因。

IF 1.3

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2026-04-17 DOI: 10.26635/6965.7302

Amy Van der Sluis, Divyansh Panesar, Richard Tapper

引用次数: 0